1. Levine, DA, Langa, KM. Vascular cognitive impairment: disease mechanisms and therapeutic implications. Neurotherapeutics 2011; 8: 361–373.
Google Scholar | Crossref | Medline2. Zlokovic, BV, Gottesman, RF, Bernstein, KE, et al. Vascular contributions to cognitive impairment and dementia (VCID): a report from the 2018 national heart, lung, and blood institute and national institute of neurological disorders and stroke workshop. Alzheimers Dement 2020; 16: 1714–1733.
Google Scholar | Crossref | Medline3. Sudduth, TL, Weekman, EM, Price, BR, et al. Time-course of glial changes in the hyperhomocysteinemia model of vascular cognitive impairment and dementia (VCID). Neuroscience 2017; 341: 42–51.
Google Scholar | Crossref | Medline | ISI4. Weekman, EM, Woolums, AE, Sudduth, TL, et al. Hyperhomocysteinemia-Induced gene expression changes in the cell types of the brain. ASN Neuro 2017; 9: 1759091417742296–175909141774.
Google Scholar | SAGE Journals | ISI5. Troen, AM, Shea-Budgell, M, Shukitt-Hale, B, et al. B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice. Proc Natl Acad Sci U S A 2008; 105: 12474–12479.
Google Scholar | Crossref | Medline | ISI6. Weekman, EM, Sudduth, TL, Price, BR, et al. Time course of neuropathological events in hyperhomocysteinemic amyloid depositing mice reveals early neuroinflammatory changes that precede amyloid changes and cerebrovascular events. J Neuroinflammation 2019; 16: 284–2020.
Google Scholar | Crossref | Medline7. Corder, EH, Saunders, AM, Strittmatter, WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921–923.
Google Scholar | Crossref | Medline | ISI8. Belloy, ME, Napolioni, V, Greicius, MD. A quarter century of APOE and Alzheimer's disease: progress to date and the path forward. Neuron 2019; 101: 820–838.
Google Scholar | Crossref | Medline9. Corder, EH, Saunders, AM, Risch, NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994; 7: 180–184.
Google Scholar | Crossref | Medline | ISI10. Rasmussen, KL, Tybjærg-Hansen, A, Nordestgaard, BG, et al. Absolute 10-year risk of dementia by age, sex and APOE genotype: a population-based cohort study. CMAJ 2018; 190: E1033–E41.
Google Scholar | Crossref | Medline11. Montagne, A, Nation, DA, Sagare, AP, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature 2020; 581: 71–76.
Google Scholar | Crossref | Medline12. Breteler, MM, Bots, ML, Ott, A, et al. Risk factors for vascular disease and dementia. Haemostasis 1998; 28: 167–173.
Google Scholar | Medline13. Lynch, JR, Tang, W, Wang, H, et al. APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem 2003; 278: 48529–48533.
Google Scholar | Crossref | Medline | ISI14. Zhu, Y, Nwabuisi-Heath, E, Dumanis, SB, et al. APOE genotype alters glial activation and loss of synaptic markers in mice. Glia 2012; 60: 559–569.
Google Scholar | Crossref | Medline15. Lanfranco, MF, Sepulveda, J, Kopetsky, G, et al. Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation. Glia 2021; 69: 1478–1493.
Google Scholar | Crossref | Medline16. Bell, RD, Winkler, EA, Singh, I, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 2012; 485: 512–516.
Google Scholar | Crossref | Medline | ISI17. Sudduth, TL, Powell, DK, Smith, CD, et al. Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation. J Cereb Blood Flow Metab 2013; 33: 708–715.
Google Scholar | SAGE Journals | ISI18. Zappasodi, F, Salustri, C, Babiloni, C, et al. An observational study on the influence of the APOE-epsilon4 allele on the correlation between ‘free' copper toxicosis and EEG activity in Alzheimer disease. Brain Res 2008; 1215: 183–189.
Google Scholar | Crossref | Medline19. Miyata, M, Smith, JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 1996; 14: 55–61.
Google Scholar | Crossref | Medline | ISI20. Zito, G, Polimanti, R, Panetta, V, et al. Antioxidant status and APOE genotype as susceptibility factors for neurodegeneration in Alzheimer's disease and vascular dementia. Rejuvenation Res 2013; 16: 51–56.
Google Scholar | Crossref | Medline21. Arbones-Mainar, JM, Johnson, LA, Altenburg, MK, et al. Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice. Int J Obes (Lond) 2008; 32: 1595–1605.
Google Scholar | Crossref | Medline | ISI22. Elosua, R, Demissie, S, Cupples, LA, et al. Obesity modulates the association among APOE genotype, insulin, and glucose in men. Obes Res 2003; 11: 1502–1508.
Google Scholar | Crossref | Medline23. Sudduth, TL, Weekman, EM, Brothers, HM, et al. Beta-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice. Alzheimers Res Ther 2014; 6: 32.
Google Scholar | Crossref | Medline24. Ducros, V, Belva-Besnet, H, Casetta, B, et al. A robust liquid chromatography tandem mass spectrometry method for total plasma homocysteine determination in clinical practice. Clin Chem Lab Med 2006; 44: 987–990.
Google Scholar | Crossref | Medline25. Arning, E, Bottiglieri, T. Quantitation of S-adenosylmethionine and S-adenosylhomocysteine in plasma using liquid chromatography-electrospray tandem mass spectrometry. Methods Mol Biol 2016; 1378: 255–262.
Google Scholar | Crossref | Medline26. Rooney, M, Bottiglieri, T, Wasek-Patterson, B, et al. Impact of the MTHFR C677T polymorphism on one-carbon metabolites: evidence from a randomised trial of riboflavin supplementation. Biochimie 2020; 173: 91–99.
Google Scholar | Crossref | Medline27. Veeranki, S, Gandhapudi, SK, Tyagi, SC. Interactions of hyperhomocysteinemia and T cell immunity in causation of hypertension. Can J Physiol Pharmacol 2017; 95: 239–246.
Google Scholar | Crossref | Medline28. Frigerio, J-M, Dagorn, J-C, Iovanna, JL. Cloning, sequencing and expression of the L5, L21, L27a, L28, S5, S9, S10 and S29 human ribosomal protein mRNAs. Biochim et Biophys Acta (BBA) – Gene Struct Expr 1995; 1262: 64–68.
Google Scholar | Crossref | Medline29. Kalsheker, NA. α1-antichymotrypsin. Int J Biochem Cell Biol 1996; 28: 961–964.
Google Scholar | Crossref | Medline | ISI30. Zhao, N, Ren, Y, Yamazaki, Y, et al. Alzheimer's risk factors age, APOE genotype, and sex drive distinct molecular pathways. Neuron 2020; 106: 727–742 e6.
Google Scholar | Crossref | Medline31. Graff-Radford, J, Simino, J, Kantarci, K, et al. Neuroimaging correlates of cerebral microbleeds: the ARIC study (atherosclerosis risk in communities). Stroke 2017; 48: 2964–2972.
Google Scholar | Crossref | Medline32. Liao, F, Yoon, H, Kim, J. Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease. Curr Opin Lipidol 2017; 28: 60–67.
Google Scholar | Crossref | Medline33. Johnson, LA. APOE and metabolic dysfunction in Alzheimer's disease. Int Rev Neurobiol 2020; 154: 131–151.
Google Scholar | Crossref | Medline34. Ravaglia, G, Forti, P, Maioli, F, et al. Apolipoprotein E e4 allele affects risk of hyperhomocysteinemia in the elderly. Am J Clin Nutr 2006; 84: 1473–1480.
Google Scholar | Crossref | Medline35. Nilsson, K, Gustafson, L, Nornholm, M, et al. Plasma homocysteine, apolipoprotein E status and vascular disease in elderly patients with mental illness. Clin Chem Lab Med 2010; 48: 129–135.
Google Scholar | Crossref | Medline36. Ruiz, J, Kouiavskaia, D, Migliorini, M, et al. The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J Lipid Res 2005; 46: 1721–1731.
Google Scholar | Crossref | Medline | ISI37. Eichner, JE, Dunn, ST, Perveen, G, et al. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 2002; 155: 487–495.
Google Scholar | Crossref | Medline | ISI38. Li, S, Arning, E, Liu, C, et al. Regulation of homocysteine homeostasis through the transcriptional coactivator PGC-1alpha. Am J Physiol Endocrinol Metab 2009; 296: E543–8.
Google Scholar | Crossref | Medline39. Giulidori, P, Galli-Kienle, M, Catto, E, et al. Transmethylation, transsulfuration, and aminopropylation reactions of S-adenosyl-L-methionine in vivo. J Biol Chem 1984; 259: 4205–4211.
Google Scholar | Crossref | Medline40. Fontecave, M, Atta, M, Mulliez, E. S-adenosylmethionine: nothing goes to waste. Trends Biochem Sci 2004; 29: 243–249.
Google Scholar | Crossref | Medline41. Dayal, S, Lentz, SR. Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler Thromb Vasc Biol 2008; 28: 1596–1605.
Google Scholar | Crossref | Medline | ISI42. Refsum, H, Ueland, PM, Nygard, O, et al. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49: 31–62.
Google Scholar | Crossref | Medline | ISI43. Forouzanfar, MH, Liu, P, Roth, GA, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA 2017; 317: 165–182.
Google Scholar | Crossref | Medline | ISI44. Bakir, S, Mori, T, Durand, J, et al. Estrogen-induced vasoprotection is estrogen receptor dependent: evidence from the balloon-injured rat carotid artery model. Circulation 2000; 101: 2342–2344.
Google Scholar | Crossref | Medline45. Xing, D, Nozell, S, Chen, YF, et al. Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol 2009; 29: 289–295.
Google Scholar | Crossref | Medline | ISI46. Li, Y, Song, Y, Zhao, L, et al. Direct labeling and visualization of blood vessels with lipophilic carbocyanine dye DiI. Nat Protoc 2008; 3: 1703–1708.
Google Scholar | Crossref | Medline | ISI47. Haile, Y, Carmine-Simmen, K, Olechowski, C, et al. Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo. J Neuroinflammation 2015; 12: 157.
Google Scholar | Crossref |